Literature DB >> 10563539

Effect of coffee on gastro-oesophageal reflux in patients with reflux disease and healthy controls.

P J Boekema1, M Samsom, A J Smout.   

Abstract

BACKGROUND: Many patients with gastro-oesophageal reflux disease (GORD) report that coffee aggravates their symptoms and doctors tend to discourage its use in GORD.
OBJECTIVE: To assess the effect of coffee ingestion on gastro-oesophageal acid reflux.
DESIGN: A randomized, controlled, crossover study. PARTICIPANTS: Seven GORD patients and eight healthy subjects.
METHODS: After 1 day of coffee abstinence, participants underwent 24-h oesophageal pH and manometric monitoring. At well-defined times, they ingested either 280 ml of regular paper-filtered coffee or 280 ml of warm water. Coffee or water was drunk 1 h after breakfast, during lunch, 1 h after dinner and after an overnight fast Reflux and oesophageal motility parameters were assessed for the first hour after each coffee or water intake.
RESULTS: Coffee had no effect on postprandial acid reflux time or number of reflux episodes, either in GORD patients or in healthy subjects. Coffee increased the percentage acid reflux time only when ingested in the fasting period in the GORD patients (median 2.6, range 0-19.3 versus median 0, range 0-8.3; P = 0.028), but not in the healthy subjects. No effect of coffee on postprandial lower oesophageal sphincter pressure (LOSP), patterns of LOSP associated with reflux episodes or oesophageal contractions was found.
CONCLUSION: Coffee has no important effect on gastro-oesophageal acid reflux in GORD patients, and no effect at all in healthy subjects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10563539     DOI: 10.1097/00042737-199911000-00015

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  12 in total

1.  A randomized, double-blind comparison of two different coffee-roasting processes on development of heartburn and dyspepsia in coffee-sensitive individuals.

Authors:  John K DiBaise
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

2.  Indian consensus on gastroesophageal reflux disease in adults: A position statement of the Indian Society of Gastroenterology.

Authors:  Shobna J Bhatia; Govind K Makharia; Philip Abraham; Naresh Bhat; Ajay Kumar; D Nageshwar Reddy; Uday C Ghoshal; Vineet Ahuja; G Venkat Rao; Krishnadas Devadas; Amit K Dutta; Abhinav Jain; Saurabh Kedia; Rohit Dama; Rakesh Kalapala; Jose Filipe Alvares; Sunil Dadhich; Vinod Kumar Dixit; Mahesh Kumar Goenka; B D Goswami; Sanjeev K Issar; Venkatakrishnan Leelakrishnan; Mohandas K Mallath; Philip Mathew; Praveen Mathew; Subhashchandra Nandwani; Cannanore Ganesh Pai; Lorance Peter; A V Siva Prasad; Devinder Singh; Jaswinder Singh Sodhi; Randhir Sud; Jayanthi Venkataraman; Vandana Midha; Amol Bapaye; Usha Dutta; Ajay K Jain; Rakesh Kochhar; Amarender S Puri; Shivram Prasad Singh; Lalit Shimpi; Ajit Sood; Rajkumar T Wadhwa
Journal:  Indian J Gastroenterol       Date:  2019-12-05

3.  Epidemiology and symptom profile of gastroesophageal reflux in the Indian population: report of the Indian Society of Gastroenterology Task Force.

Authors:  Shobna J Bhatia; D Nageshwar Reddy; Uday C Ghoshal; V Jayanthi; Philip Abraham; Gourdas Choudhuri; S L Broor; Vineet Ahuja; Philip Augustine; V Balakrishnan; D K Bhasin; Naresh Bhat; Ashok Chacko; Sunil Dadhich; G K Dhali; Pankaj S Dhawan; Manisha Dwivedi; Mahesh K Goenka; Abraham Koshy; Ajay Kumar; Sri Prakash Misra; Shrikant Mukewar; E PedaVeer Raju; K T Shenoy; S P Singh; Ajit Sood; R Srinivasan
Journal:  Indian J Gastroenterol       Date:  2011-07-27

4.  Development of scores assessing the refluxogenic potential of diet of patients with laryngopharyngeal reflux.

Authors:  Jerome R Lechien; Francois Bobin; Francois Mouawad; Karol Zelenik; Christian Calvo-Henriquez; Carlos M Chiesa-Estomba; Necati Enver; Andrea Nacci; Maria Rosaria Barillari; Antonio Schindler; Lise Crevier-Buchman; Stéphane Hans; Virginie Simeone; Elzbieta Wlodarczyk; Bernard Harmegnies; Marc Remacle; Alexandra Rodriguez; Didier Dequanter; Pierre Eisendrath; Giovanni Dapri; Camille Finck; Petros Karkos; Hillevi Pendleton; Tareck Ayad; Vinciane Muls; Sven Saussez
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-09-12       Impact factor: 2.503

Review 5.  Body weight, lifestyle, dietary habits and gastroesophageal reflux disease.

Authors:  Davide Festi; Eleonora Scaioli; Fabio Baldi; Amanda Vestito; Francesca Pasqui; Anna Rita Di Biase; Antonio Colecchia
Journal:  World J Gastroenterol       Date:  2009-04-14       Impact factor: 5.742

6.  Dietary intervention in the treatment of patients with cough and symptoms suggestive of airways reflux as determined by Hull airways Reflux Questionnaire.

Authors:  Joanna Elizabeth Smith; Jaymin Bhagwanji Morjaria; Alyn Hugh Morice
Journal:  Cough       Date:  2013-12-31

7.  Alcohol and tea consumption are associated with asymptomatic erosive esophagitis in Taiwanese men.

Authors:  Chung-Hsin Chang; Cheng-Pin Wu; Jung-Der Wang; Shou-Wu Lee; Chi-Sen Chang; Hong-Zen Yeh; Chung-Wang Ko; Han-Chung Lien
Journal:  PLoS One       Date:  2017-03-06       Impact factor: 3.240

8.  Prevalence and clinical predictors of LPR among patients diagnosed with GERD according to the reflux symptom index questionnaire.

Authors:  Mahmoud Mosli; Bashaer Alkhathlan; Abdulmalik Abumohssin; Mazin Merdad; Ameen Alherabi; Osama Marglani; Hani Jawa; Talal Alkhatib; Hani Z Marzouki
Journal:  Saudi J Gastroenterol       Date:  2018 Jul-Aug       Impact factor: 2.485

9.  Association between tea consumption and gastroesophageal reflux disease: A meta-analysis.

Authors:  Hongying Cao; Xiaoyi Huang; Xiaosong Zhi; Cuihong Han; Liang Li; Yuyi Li
Journal:  Medicine (Baltimore)       Date:  2019-01       Impact factor: 1.817

10.  Lifestyle changes as a treatment of gastroesophageal reflux disease: a survey of general practitioners in North Queensland, Australia.

Authors:  Madeleine Nowak; Petra Büttner; Beverly Raasch; Kym Daniell; Cindy McCutchan; Simone Harrison
Journal:  Ther Clin Risk Manag       Date:  2005-09       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.